The anti-cancer capability of the Klf1(K74R) mice has rendered them relatively free from spontaneous cancer occurrence (Shyu et al., 2022), which is also reflected by their resistance to tumorigenesis of the B16-F10 cells and Hepa1-6 in the anti-cancer assays (Figures 1—3). This evidence concerns the gene KLF1 and cancer.